Sintx Technologies Inc (SINT) Stock Price, Quote & News

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (P...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 839 3500

Website: www.sintx.com

Address:

1885 West 2100 South, Salt Lake City, United States

SnoopyDog Aug. 19 at 12:31 PM

$SINT and another effective S3 lol

0 · Reply

SnoopyDog Aug. 19 at 4:49 AM

$SINT "create shareholder value" = sell new shares and give millions of warrants for free:)

0 · Reply

The_Gambl3r Aug. 18 at 11:09 PM

$SINT

0 · Reply

SnoopyDog Aug. 18 at 4:00 AM

$SINT NEVER saw that and never will see that. SEC doesnt care

0 · Reply

SnoopyDog Aug. 18 at 3:59 AM

$SINT you say so. Why not contacting SEC several years ago? Nothing changed, its still the same SCAM as under Sonny. There are a lot of people melking this, except for retail. Its only a playbook. SEC will not care they never cared

0 · Reply

Boston7452 Aug. 17 at 2:26 PM

$SINT it does matter. Sintx is sitting on billion dollar IP, I’ve shown the potential. If they are not using it because they are trying to bring about another RS that’s all sorts of illegal and shareholder can contact the SEC and need to do so now. Sec can stop Medtechs new warrants with full ratchet provision. That’s when shit could get really bad when Medtech and June offering folk go back n forth driving the price down. Contacting the Sec could also lead to clawback of those June warrants like none of this happened. Lastly shareholders should contact the SEC to find out if Sintx did give Ned Medical anything in that settled lawsuit it’s still hiding. If Managemt gave away IP at all they’ve effectively stolen from the company. Sec needs to get involved. To Summarize, shareholders contact the sec now!

1 · Reply

SnoopyDog Aug. 17 at 8:10 AM

$SINT doesnt matter. Its just SCAM and ever was

0 · Reply

Boston7452 Aug. 16 at 6:29 PM

$SINT snoop you’ve said mgmt is using Sonny’s playbook which means to flood market with shares and force a RS. if mgmt is doing this to fix their mistake in 2024 that will not work and they’ve only further exposed themselves.

2 · Reply

Boston7452 Aug. 14 at 9:29 PM

$SINT management is just sitting on this very valuable and transformative IP. Isn’t this some form of IP underutilization and asset neglect?

0 · Reply

SnoopyDog Aug. 14 at 7:37 PM

$SINT thought so, No source

1 · Reply

Sintx Technologies files to sell 1.27M shares of common stock for holders

SINT

Aug 13, 2026, 9:00 AM EDT - 6 days ago

SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement

SINT

Aug 13, 2026, 8:00 AM EDT - 6 days ago

Sintx Technologies Registration statement: Registration filing

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Sintx Technologies Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Sintx Technologies Quarterly report: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 7 days ago

Sintx Technologies Earnings release: Q2 2026

Aug 11, 2026, 4:06 PM EDT - 7 days ago

SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

SINT

Jul 28, 2026, 9:00 AM EDT - 22 days ago

SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

SINT

Jul 23, 2026, 9:00 AM EDT - 27 days ago

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

SINT

Jun 25, 2026, 8:00 AM EDT - 7 weeks ago

Sintx Technologies Registration statement: Registration filing

2026-06-25T10:05:39.000Z - 7 weeks ago

Sintx Technologies files to sell 5.82M shares of common stock for holders

SINT

2026-06-22T14:00:56.000Z - 2 months ago

Sintx Technologies receives $3.2M in purchase orders

SINT

Jun 22, 2026, 9:00 AM EDT - 2 months ago

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

SINT

Jun 15, 2026, 11:13 AM EDT - 2 months ago

Sintx Technologies Transcript: Transcript

2026-06-04T11:45:10.000Z - 2 months ago

Sintx Technologies resumed with a Buy at Maxim

SINT

Jun 3, 2026, 9:00 AM EDT - 2 months ago

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

SINT

May 17, 2026, 3:30 PM EDT - 3 months ago

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

SINT

2026-04-13T10:11:23.000Z - 4 months ago

Sintx Technologies initiated with a Buy at H.C. Wainwright

SINT

Mar 23, 2026, 9:15 AM EDT - 5 months ago

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

SINT

2026-03-19T11:51:39.000Z - 5 months ago

Sintx Technologies announces first in-human surgery using FDA-cleared Sinaptic

SINT

Mar 19, 2026, 7:30 AM EDT - 5 months ago

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

SINT

2026-02-18T13:40:31.000Z - 6 months ago

Sintx Technologies appoints Elmore as President

SINT

Feb 18, 2026, 8:30 AM EST - 6 months ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINT

Jan 29, 2026, 9:00 AM EST - 7 months ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SINT

2025-12-01T13:35:45.000Z - 9 months ago

Sintx Technologies signs supply agreement with EVONIK

SINT

Dec 1, 2025, 8:30 AM EST - 9 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINT

2025-11-13T13:05:19.000Z - 9 months ago

Sintx Technologies reports Q3 EPS ($3.46) vs ($6.96) last year

SINT

Nov 13, 2025, 7:00 AM EST - 9 months ago

Sintx Technologies Earnings release: Q3 2025

2025-11-03T13:05:41.000Z - 10 months ago

Sintx Technologies announces launch of OsseoSculpt

SINT

Nov 3, 2025, 8:00 AM EST - 10 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINT

2025-10-23T20:40:36.000Z - 10 months ago

Sintx Technologies files to sell 1.74M shares of common stock for holders

SINT

Oct 20, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINT

2025-10-14T11:11:00.000Z - 11 months ago

Sintx Technologies announces U.S. patent notice of allowance

SINT

Oct 14, 2025, 7:00 AM EDT - 11 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINT

2025-09-30T20:55:10.000Z - 11 months ago

Sintx Technologies files to sell 541,450 shares of common stock for holders

SINT

2025-09-08T12:01:04.000Z - 1 year ago

Sintx Technologies announces exercise of warrants for $3.8M gross proceeds

SINT

Sep 8, 2025, 7:54 AM EDT - 1 year ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINT

2025-09-08T11:25:37.000Z - 1 year ago

Sintx Technologies receives USPTO notice of allowance

SINT

Sep 8, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINT

2025-09-03T11:10:22.000Z - 1 year ago

Sintx Technologies publishes study of antiviral activity of Silicon Nitride

SINT

2025-08-15T11:11:47.000Z - 1 year ago

Sintx Technologies issues business update following strategic realignment

SINT

Aug 15, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINT

Aug 4, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINT

2025-07-22T11:10:59.000Z - 1 year ago

Sintx Technologies submits FDA 510k for silicon nitride foot, ankle devices

SINT

Jun 24, 2025, 8:30 AM EDT - 1 year ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINT

May 22, 2025, 7:00 AM EDT - 1 year ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINT

May 15, 2025, 7:05 AM EDT - 1 year ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINT

May 15, 2025, 7:00 AM EDT - 1 year ago

Sintx Technologies Earnings release: Q1 2025

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINT

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINT

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINT

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINT

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINT

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINT

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINT

Oct 1, 2024, 8:00 AM EDT - 2 years ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

SINT

Sep 20, 2024, 8:00 AM EDT - 2 years ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINT

Sep 9, 2024, 8:00 AM EDT - 2 years ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINT

Jun 18, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies to Explore Strategic Opportunities

SINT

Jun 12, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINT

Jun 6, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINT

May 23, 2024, 9:00 AM EDT - 2 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINT

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINT

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINT

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

SINT

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINT

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINT

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINT

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINT

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINT

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINT

Nov 7, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

SINT

Oct 11, 2023, 9:00 AM EDT - 3 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

SINT

Aug 17, 2023, 9:00 AM EDT - 3 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINT

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINT

SnoopyDog Aug. 19 at 12:31 PM

$SINT and another effective S3 lol

0 · Reply

SnoopyDog Aug. 19 at 4:49 AM

$SINT "create shareholder value" = sell new shares and give millions of warrants for free:)

0 · Reply

The_Gambl3r Aug. 18 at 11:09 PM

$SINT

0 · Reply

SnoopyDog Aug. 18 at 4:00 AM

$SINT NEVER saw that and never will see that. SEC doesnt care

0 · Reply

SnoopyDog Aug. 18 at 3:59 AM

0 · Reply

Boston7452 Aug. 17 at 2:26 PM

1 · Reply

SnoopyDog Aug. 17 at 8:10 AM

$SINT doesnt matter. Its just SCAM and ever was

0 · Reply

Boston7452 Aug. 16 at 6:29 PM

2 · Reply

Boston7452 Aug. 14 at 9:29 PM

$SINT management is just sitting on this very valuable and transformative IP. Isn’t this some form of IP underutilization and asset neglect?

0 · Reply

SnoopyDog Aug. 14 at 7:37 PM

$SINT thought so, No source

1 · Reply

Boston7452 Aug. 14 at 6:47 PM

$SINT "You have highlighted what might be the single most disruptive, high-margin asset in SINTX's entire intellectual property portfolio: U.S. Patent No. 12,239,761 (“Methods of Silicon Nitride Laser Cladding”). This patent completely shatters the operational boundaries of advanced ceramics. Instead of forcing orthopedic device giants to abandon their existing manufacturing pipelines to buy solid ceramic shapes from SINTX, this technology allows them to upgrade any standard medical implant into a bioactive powerhouse."

1 · Reply

Boston7452 Aug. 14 at 6:17 PM

$SINT Correction: "The Bleichroeder Allocation: The block of shares and warrants associated with Bleichroeder belongs specifically to the Nina Gorrissen 2014 Trust. Michael M. Kellen acts as the trustee. Since the Kellen family has deep leadership ties within Bleichroeder, the trust's money is managed internally by Bleichroeder's advisory team " Still the same end result in that their filing has to do with them managing shares from the June offering.

1 · Reply

Boston7452 Aug. 14 at 5:45 PM

$SINT Ignore the Sintx 20% as thats not correct. Sintx royalties will vary based on which tier of combosphere is being sold. Theres technically 4 products 1 TAE, 1 TARE, 1 TACE, and the flagship that combines the 3 tiers together. Flagship tier should see a royalty of 15% or so because of how crucial Sintx material is to making Combisphere work and biodegrade for future additional treatments if needed. This is a monopoly product, no other company could compete with this!

1 · Reply

Boston7452 Aug. 14 at 5:14 PM

$SINT So its not their shares but Stonepines and Bleichroeder is managing them. "Bleichroeder didn't buy these directly from SINTX on its own ledger. They gained investment control over them because Stonepine Capital purchased the bundle in the private placement and allocates management/discretionary power over that block of 523,013 shares and 124,500 warrants to Bleichroeder. Therefore, Stonepine remains the registered "selling stockholder" on record for the underlying registration statement"

0 · Reply

Boston7452 Aug. 14 at 5:09 PM

$SINT "If there was no 9.99% limit on the exercise of warrants, Bleichroeder would be deemed to be the beneficial owner of 1,569,039 shares of common stock, representing 21.19% of the outstanding shares of common stock." I thought it was 21.9 so i rounded to 22, looks like closer to 21%

0 · Reply

SnoopyDog Aug. 14 at 4:37 PM

$SINT source please

0 · Reply

SnoopyDog Aug. 14 at 4:37 PM

$SINT wrong information Boston

0 · Reply

Boston7452 Aug. 14 at 2:52 PM

$SINT actually they hold ~22%. They are only allow to vote based on 10%

0 · Reply

Boston7452 Aug. 14 at 2:49 PM

$SINT looks like they acquired the shares from June offering holders. Also the fund appears to be connected to Siemens/Varian Medical suggesting that deal is coming soon.

0 · Reply

SnoopyDog Aug. 14 at 1:27 PM

$SINT with the right to dilute a million more shares :)

0 · Reply

Brandon6161 Aug. 14 at 12:55 PM

$SINT 13G filing. Andrew Gundlach 9.99% holder

0 · Reply

SnoopyDog Aug. 14 at 6:56 AM

$SINT alot of toxic deals lately. Thats the shareholder value they create :) i remember Sonny doing the same deals for years :) friends help friends

0 · Reply

Market Cap	7.08M
Revenue (ttm)	1.02M
Net Income (ttm)	-10.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,015.69%
Debt to Equity Ratio	0.02

Volume	37,500
Avg Vol	119,482
Day's Range	N/A - N/A
Shares Out	4.32M
Stochastic %K	34%
Beta	0.62
Analysts	Sell
Price Target	$11.00